Dissecting cancer pathways and vulnerabilities with RNAi.
about
High-throughput screening using siRNA (RNAi) libraries.RNAi screening: new approaches, understandings, and organisms.WT1: a weak spot in KRAS-induced transformationMAPK7 Regulates EMT Features and Modulates the Generation of CTCs.A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia.Genetically engineered mouse models in cancer researchDNA repair gene variants in relation to overall cancer risk: a population-based studyKinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells.Loss-of-function genetic tools for animal models: cross-species and cross-platform differences.Functional drug-gene interactions in lung cancer.A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers.A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments.PGBD5 promotes site-specific oncogenic mutations in human tumors.Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors.Large-Scale RNA Interference Screening to Identify Transcriptional Regulators of a Tumor Suppressor Gene.Transcriptional Analysis-Based Integrative Genomics Approach to Identify Tumor-Promoting Metabolic Genes.
P2860
Q33284130-18DB695C-17C9-44E8-B264-4F9632C2299BQ34033373-D88D9DEF-C8CB-465F-A930-1BA7BEC9815AQ34245506-6CAD1749-886E-48DB-ADF4-908710344D08Q35560430-BBFAF069-91C7-4B38-85BB-3AC9CDE3AFFEQ35983871-8686E1D4-4395-4B7C-B4CC-A01B6C7EF8ADQ36223356-2AF86116-F3CB-4072-8842-CEB83B32F959Q36497718-BC2E0D10-EEEC-4D17-AC7B-AA3BB42B045EQ36499747-7EAAB61A-609D-47E6-8932-A31F1C13F9DEQ36954856-C821660A-F251-4A06-8211-226C40A9715BQ37550614-72B6EF4B-2B76-49FB-8D21-08917E4BA9DFQ37999073-F0C253EC-A9EA-4420-9D7F-04E5E262E4A7Q39374283-8F6A82CC-6BB6-48BF-9EB3-039CDDF2CA96Q39559549-6A4D8736-5C6B-496C-8DA7-AF92A1EA293DQ40201338-41483C76-84B5-4C28-BDC1-A01C2C262F37Q46062200-1E54F264-4C93-45CA-8700-A4341418E2D7Q48938509-F42C204F-1BA5-497A-9C12-64C738653271Q50356845-D5687DA2-0804-4CDC-AD19-3A4FE71948AF
P2860
Dissecting cancer pathways and vulnerabilities with RNAi.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Dissecting cancer pathways and vulnerabilities with RNAi.
@ast
Dissecting cancer pathways and vulnerabilities with RNAi.
@en
type
label
Dissecting cancer pathways and vulnerabilities with RNAi.
@ast
Dissecting cancer pathways and vulnerabilities with RNAi.
@en
prefLabel
Dissecting cancer pathways and vulnerabilities with RNAi.
@ast
Dissecting cancer pathways and vulnerabilities with RNAi.
@en
P2093
P2860
P356
P1476
Dissecting cancer pathways and vulnerabilities with RNAi.
@en
P2093
Elledge SJ
Stegmeier F
Westbrook TF
P2860
P304
P356
10.1101/SQB.2005.70.031
P577
2005-01-01T00:00:00Z